Abstract
Aims
Eating protein before carbohydrate reduces postprandial glucose excursions by enhancing insulin and glucagon-like peptide-1 (GLP-1) secretion in type 2 diabetes (T2D). We tested the hypothesis that this insulinotropic effect depends on the elevation of plasma amino acids (AA) after the digestion of food protein.
Methods
In 16 T2D patients, we measured plasma AA levels through the course of two 75-g oral glucose tolerance tests (OGTT) preceded by either 500-ml water or a high-protein nutrient preload (50-g Parmesan cheese, one boiled egg, and 300-ml water). Changes in beta cell function were evaluated by measuring and modelling plasma glucose, insulin, and C-peptide through the OGTT. Changes in incretin hormone secretion were assessed by measuring plasma GLP-1.
Results
Plasma AA levels were 24% higher after the nutrient preload (p < 0.0001). This increment was directly proportional to both the enhancement of beta cell function (r = 0.58, p = 0.02) and the plasma GLP-1 gradients (r = 0.57, p = 0.02) produced by the nutrient preload. Among single AA, glutamine showed the strongest correlation with changes in beta cell function (r = 0.61, p = 0.01), while leucine showed the strongest correlation with GLP-1 responses (r = 0.74, p = 0.001).
Conclusions
The elevation of circulating AA that occurs after a high-protein nutrient preload is associated with an enhancement of beta cell function and GLP-1 secretion in T2D. Manipulating the meal sequence of nutrient ingestion may reduce postprandial hyperglycaemia through a direct and GLP-1-mediated stimulation of insulin secretion by plasma AA.
Trial registration number
NCT02342834.
Similar content being viewed by others
Abbreviations
- AA:
-
Amino acids
- AUC:
-
Area under the curve
- GLP-1:
-
Glucagon-like peptide 1
- ISR:
-
Insulin secretion rate
- ISR@FPG:
-
Insulin secretion rate at fasting plasma glucose
- T2D:
-
Type 2 diabetes
References
Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr, American Diabetes A (2013) Nutrition therapy recommendations for the management of adults with diabetes. Diabetes care 36(11):3821–3842. https://doi.org/10.2337/dc13-2042
Efeyan A, Comb WC, Sabatini DM (2015) Nutrient-sensing mechanisms and pathways. Nature 517(7534):302–310. https://doi.org/10.1038/nature14190
Tricò D, Filice E, Trifirò S, Natali A (2016) Manipulating the sequence of food ingestion improves glycemic control in type 2 diabetic patients under free-living conditions. Nutr Diabetes 6(8):e226. https://doi.org/10.1038/nutd.2016.33
Tricò D, Natali A (2017) Modulation of postprandial glycemic responses by noncarbohydrate nutrients provides novel approaches to the prevention and treatment of type 2 diabetes. Am J Clin Nutr 106(2):701–702. https://doi.org/10.3945/ajcn.117.157255
Shukla AP, Iliescu RG, Thomas CE, Aronne LJ (2015) Food order has a significant impact on postprandial glucose and insulin levels. Diabetes Care 38(7):e98–e99. https://doi.org/10.2337/dc15-0429
Kuwata H, Iwasaki M, Shimizu S, Minami K, Maeda H, Seino S, Nakada K, Nosaka C, Murotani K, Kurose T, Seino Y, Yabe D (2016) Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial. Diabetologia 59(3):453–461. https://doi.org/10.1007/s00125-015-3841-z
Ma J, Jesudason DR, Stevens JE, Keogh JB, Jones KL, Clifton PM, Horowitz M, Rayner CK (2015) Sustained effects of a protein ‘preload’ on glycaemia and gastric emptying over 4 weeks in patients with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract 108(2):e31–e34. https://doi.org/10.1016/j.diabres.2015.02.019
Imai S, Fukui M, Ozasa N, Ozeki T, Kurokawa M, Komatsu T, Kajiyama S (2013) Eating vegetables before carbohydrates improves postprandial glucose excursions. Diabet Med 30(3):370–372. https://doi.org/10.1111/dme.12073
Tricò D, Baldi S, Tulipani A, Frascerra S, Macedo MP, Mari A, Ferrannini E, Natali A (2015) Mechanisms through which a small protein and lipid preload improves glucose tolerance. Diabetologia 58(11):2503–2512. https://doi.org/10.1007/s00125-015-3710-9
Tricò D, Filice E, Baldi S, Frascerra S, Mari A, Natali A (2016) Sustained effects of a protein and lipid preload on glucose tolerance in type 2 diabetes patients. Diabetes Metab 42(4):242–248. https://doi.org/10.1016/j.diabet.2016.03.004
Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones KL, Clifton PM, Horowitz M, Rayner CK (2009) Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 32(9):1600–1602. https://doi.org/10.2337/dc09-0723
Nauck MA, Baller B, Meier JJ (2004) Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes. Diabetes 53(Suppl 3):S190–S196
Carr RD, Larsen MO, Winzell MS, Jelic K, Lindgren O, Deacon CF, Ahren B (2008) Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am J PHYSIOL ENDOCRINOL METAB 295(4):E779–E784. https://doi.org/10.1152/ajpendo.90233.2008
Lindgren O, Pacini G, Tura A, Holst JJ, Deacon CF, Ahren B (2015) Incretin effect after oral amino acid ingestion in humans. J Clin Endocrinol Metab 100(3):1172–1176. https://doi.org/10.1210/jc.2014-3865
Nuttall FQ, Gannon MC (1991) Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects. Diabetes Care 14(9):824–838
Natali A, Baldi S, Bonnet F, Petrie J, Trifirò S, Tricò D, Mari A, Investigators R (2017) Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects. Metabolism 69:33–42. https://doi.org/10.1016/j.metabol.2017.01.001
Floyd JC Jr, Fajans SS, Conn JW, Knopf RF, Rull J (1966) Stimulation of insulin secretion by amino acids. J Clin Invest 45(9):1487–1502. https://doi.org/10.1172/JCI105456
van Loon LJ, Saris WH, Verhagen H, Wagenmakers AJ (2000) Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. Am J Clin Nutr 72(1):96–105
Floyd JC Jr, Fajans SS, Pek S, Thiffault CA, Knopf RF, Conn JW (1970) Synergistic effect of certain amino acid pairs upon insulin secretion in man. Diabetes 19(2):102–108
Newsholme P, Cruzat V, Arfuso F, Keane K (2014) Nutrient regulation of insulin secretion and action. J Endocrinol 221(3):R105–R120. https://doi.org/10.1530/JOE-13-0616
American Diabetes Association (2017) Classification and diagnosis of diabetes, standards of medical care in diabetes. Diabetes Care 40(Suppl 1):S11–S24. https://doi.org/10.2337/dc17-S005
Buzzigoli G, Lanzone L, Ciociaro D, Frascerra S, Cerri M, Scandroglio A, Coldani R, Ferrannini E (1990) Characterization of a reversed-phase high-performance liquid chromatographic system for the determination of blood amino acids. J Chromatogr 507:85–93
Muscelli E, Frascerra S, Casolaro A, Baldi S, Mari A, Gall W, Cobb J, Ferrannini E (2014) The amino acid response to a mixed meal in patients with type 2 diabetes: effect of sitagliptin treatment. Diabetes Obes Metab 16(11):1140–1147. https://doi.org/10.1111/dom.12350
Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41(3):368–377
Mari A, Ferrannini E (2008) Beta-cell function assessment from modelling of oral tests: an effective approach. Diabetes Obes Metab 10 Suppl 4:77–87. https://doi.org/10.1111/j.1463-1326.2008.00946.x
Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283(6):E1159–E1166. https://doi.org/10.1152/ajpendo.00093.2002
Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24(3):539–548
Wu T, Little TJ, Bound MJ, Borg M, Zhang X, Deacon CF, Horowitz M, Jones KL, Rayner CK (2016) A protein preload enhances the glucose-lowering efficacy of Vildagliptin in type 2 diabetes. Diabetes Care 39(4):511–517. https://doi.org/10.2337/dc15-2298
Berger S, Vongaraya N (1966) Insulin response to ingested protein in diabetes. Diabetes 15(5):303–306
Rabinowitz D, Merimee TJ, Maffezzoli R, Burgess JA (1966) Patterns of hormonal release after glucose, protein, and glucose plus protein. Lancet 2(7461):454–456
Nuttall FQ, Mooradian AD, Gannon MC, Billington C, Krezowski P (1984) Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care 7(5):465–470
Gannon MC, Nuttall FQ, Neil BJ, Westphal SA (1988) The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects. Metabolism 37(11):1081–1088
Gannon MC, Nuttall FQ, Lane JT, Burmeister LA (1992) Metabolic response to cottage cheese or egg white protein, with or without glucose, in type II diabetic subjects. Metabolism 41(10):1137–1145
van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH, Keizer HA (2003) Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 26(3):625–630
Sener A, Malaisse WJ (1981) The stimulus-secretion coupling of amino acid-induced insulin release: insulinotropic action of branched-chain amino acids at physiological concentrations of glucose and glutamine. Eur J Clin Invest 11(6):455–460
McClenaghan NH, Barnett CR, O’Harte FP, Flatt PR (1996) Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic B-cell line. J Endocrinol 151(3):349–357
Schmid R, Schulte-Frohlinde E, Schusdziarra V, Neubauer J, Stegmann M, Maier V, Classen M (1992) Contribution of postprandial amino acid levels to stimulation of insulin, glucagon, and pancreatic polypeptide in humans. Pancreas 7(6):698–704
Calbet JA, MacLean DA (2002) Plasma glucagon and insulin responses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans. J Nutr 132(8):2174–2182
Gannon MC, Nuttall FQ (2010) Amino acid ingestion and glucose metabolism—a review. IUBMB Life 62(9):660–668. https://doi.org/10.1002/iub.375
Sener A, Malaisse WJ (1980) L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288(5787):187–189
Li C, Buettger C, Kwagh J, Matter A, Daikhin Y, Nissim IB, Collins HW, Yudkoff M, Stanley CA, Matschinsky FM (2004) A signaling role of glutamine in insulin secretion. J Biol Chem 279(14):13393–13401. https://doi.org/10.1074/jbc.M311502200
Chen Q, Reimer RA (2009) Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro. Nutrition 25(3):340–349. https://doi.org/10.1016/j.nut.2008.08.012
Gojda J, Strakova R, Plihalova A, Tuma P, Potockova J, Polak J, Andel M (2017) Increased incretin but not insulin response after oral versus intravenous branched chain amino acids. Ann Nutr Metab 70(4):293–302. https://doi.org/10.1159/000475604
Tricò D, Herzog RI (2017) Metabolic brain adaptations to recurrent hypoglycaemia may explain the link between type 1 diabetes mellitus and epilepsy and point towards future study and treatment options. Diabetologia 60(5):938–939. https://doi.org/10.1007/s00125-017-4231-5
Seghieri M, Tricò D, Natali A (2017) The impact of triglycerides on glucose tolerance: lipotoxicity revisited. Diabetes Metab 43(4):314–322. https://doi.org/10.1016/j.diabet.2017.04.010
Tricò D, Di Sessa A, Caprio S, Chalasani N, Liu W, Liang T, Graf J, Herzog RI, Johnson CD, Umano GR, Feldstein AE, Santoro N (2017) Oxidized derivatives of linoleic acid in pediatric metabolic syndrome: is their pathogenic role modulated by the genetic background and the gut microbiota? Antioxid Redox Signal. https://doi.org/10.1089/ars.2017.7049 (in press)
Ahren B (2000) Autonomic regulation of islet hormone secretion—implications for health and disease. Diabetologia 43(4):393–410. https://doi.org/10.1007/s001250051322
Tricò D, Prinsen H, Giannini C, de Graaf R, Juchem C, Li F, Caprio S, Santoro N, Herzog RI (2017) Elevated alpha-hydroxybutyrate and branched-chain amino acid levels predict deterioration of glycemic control in adolescents. J Clin Endocrinol Metab 102(7):2473–2481. https://doi.org/10.1210/jc.2017-00475
Goffredo M, Santoro N, Tricò D, Giannini C, D’Adamo E, Zhao H, Peng G, Yu X, Lam TT, Pierpont B, Caprio S, Herzog RI (2017) A branched-chain amino acid-related metabolic signature characterizes obese adolescents with non-alcoholic fatty liver disease. Nutrients 9(7):E642. https://doi.org/10.3390/nu9070642
Acknowledgements
We would like to thank the volunteers enrolled in this trial and all the personnel of the Nutrition, Metabolism and Atherosclerosis Laboratory at the University of Pisa.
Funding
This work was supported by Grants from the University of Pisa (Fondi di Ateneo).
Author information
Authors and Affiliations
Contributions
DT conceived and designed the study, conducted the clinical studies, provided a substantial contribution to the acquisition, analysis, and interpretation of the data, and wrote the manuscript. SF and SB provided a substantial contribution to the data collection and analysis. AMe and LN provided a substantial contribution to the analysis and interpretation of the data. AMa provided a substantial contribution to the generation and interpretation of the data from the mathematical model of beta cell function and insulin sensitivity. AN conceived and designed the study, provided a substantial contribution to the analysis and interpretation of the data, and critically revised the manuscript. All authors revised the manuscript and approved the final version of the article. DT and AN are responsible for the integrity of the data and the accuracy of the data analysis.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tricò, D., Frascerra, S., Baldi, S. et al. The insulinotropic effect of a high-protein nutrient preload is mediated by the increase of plasma amino acids in type 2 diabetes. Eur J Nutr 58, 2253–2261 (2019). https://doi.org/10.1007/s00394-018-1778-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-018-1778-y